Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
MedPlus Health Services Ltd. ( (IN:MEDPLUS) ) has issued an update.
MedPlus Health Services Ltd. announced that its subsidiary, Optival Health Solutions Private Limited, has received suspension orders for drug licenses at two of its stores in Karnataka. The suspensions, issued under the Drugs and Cosmetics Act and Rules, are for one day at a store in Hampi Nagar and three days at a store in Vijayapura, potentially resulting in a revenue loss of approximately Rs 0.91 lacs and Rs 0.54 lacs respectively. This development may impact the company’s financial operations and highlights regulatory challenges in maintaining compliance with drug control standards.
More about MedPlus Health Services Ltd.
MedPlus Health Services Ltd. operates in the healthcare industry, primarily focusing on providing pharmacy retail services. The company is known for its extensive network of stores across India, offering a wide range of pharmaceutical products and health-related services.
YTD Price Performance: -6.21%
Average Trading Volume: 6,186
Current Market Cap: 95.26B INR
See more insights into MEDPLUS stock on TipRanks’ Stock Analysis page.